Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $36.5M $30.0M $25.9M $8.2M $20.1M $13.9M $8.2M $1.8M
Accounts Receivable $11.1M $8.1M $4.8M $2.9M $1.9M $1.1M $797.7K $407.4K
Inventory $7.3M $5.5M $3.9M $3.2M $3.4M $3.2M $1.8M $1.9M
Total Current Assets $55.7M $44.0M $35.1M $14.4M $25.7M $18.3M $10.9M $5.3M
Property, Plant & Equipment $2.2M $1.5M $970.9K $619.0K $381.7K $108.5K $247.8K $500.7K
Goodwill — — — — — — $170.0K $0
Intangible Assets (Excl. Goodwill) $937.0K $829.0K $678.1K $577.2K $570.4K $573.7K $899.5K $637.8K
Total Assets $58.9M $46.4M $36.7M $16.4M $27.7M $20.2M $12.5M $6.4M
Liabilities
Accounts Payable $3.2M $3.6M $2.1M $1.2M $1.2M $1.5M $1.6M $967.9K
Total Current Liabilities $13.7M $11.1M $3.7M $2.4M $2.1M $1.5M $2.0M $9.4M
Long-Term Debt $19.8M $20.3M $24.7M $25.1M $25.4M $21.6M $4.4M $0
Total Liabilities $33.7M $31.4M $28.5M $27.6M $27.5M $23.1M $6.4M $18.1M
Stockholders' Equity
Retained Earnings $-128.3M $-117.9M $-103.5M $-90.1M $-72.4M $-57.8M $-48.4M $-38.2M
Total Stockholders' Equity $25.2M $14.9M $8.2M $-11.2M $136.6K $-2.8M $6.1M $-27.1M
← Newer Page 2 of 2 Older →